ニコチン作動薬
Andrés; Wonnacott, Susan (2005), “From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research”, Drug Discovery Today 10 (23–24): 1657–1665, doi:10.1016/S1359-6446(05)03665-2, hdl:10533/176659, PMID 16376826
↑ Gotti, C.; Fornasari, D.; Clementi, F. (1997), “Human Neuronal Nicotinc Receptors”, Progress in Neurobiology 53 (2): 199–237, doi:10.1016/S0301-0082(97)00034-8, PMID 9364611
↑ Tøndera, Janne E.; Olesena, Preben H.; Hansena, John Bondo; Begtrupb, Mikael; Petterssona, Ingrid (2001), “An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by [3H]-N-methylcarbamylcholine”, Journal of Computer-Aided Molecular Design 15 (3): 247–258, Bibcode: 2001JCAMD.